WeightWatchers Stock Drops Amid GLP-1 Drug Impact
Shares of WeightWatchers fell 6.4% as the company's press release indicated that increased use of GLP-1 weight-loss drugs is still negatively impacting demand for its traditional diet programs.
Shares of WeightWatchers fell 6.4% as the company's press release indicated that increased use of GLP-1 weight-loss drugs is still negatively impacting demand for its traditional diet programs.